Evidence map›Paper›PMID 42088778›Full record

ArticleCase reports in ophthalmological medicine2026

Phakomatosis Pigmentovascularis (Type IIb) With Bilateral Glaucoma and Urrets-Zavalia Syndrome Following MicroPulse TSCPC: A Case Report.

Ali Alshehri, Yasser Bin Thabet, Mohammed Naji Almutairi

Abstract read
In one paragraph

Article in Case reports in ophthalmological medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ali AlshehriOphthalmology Department, Glaucoma Department, Prince Sultan Military Medical City, Riyadh, Saudi Arabia, psmmc.med.sa.
Yasser Bin ThabetOphthalmology Department, Glaucoma Department, Prince Sultan Military Medical City, Riyadh, Saudi Arabia, psmmc.med.sa.
Mohammed Naji AlmutairiCollege of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia, ksau-hs.edu.sa.ORCID https://orcid.org/0009-0007-8434-3148

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: We are aimed at describing the clinical course and management of a rare case of phakomatosis pigmentovascularis (PPV Type IIb) presenting with bilateral glaucoma, complicated by bilateral Urrets-Zavalia syndrome (UZS) following MicroPulse transscleral cyclophotocoagulation (MP-TSCPC). Observations: A 6-year-old girl with PPV Type IIb and syndromic glaucoma underwent MP-TSCPC as an initial surgical intervention for uncontrolled intraocular pressure (IOP). Postoperatively, the patient developed bilateral fixed dilated pupils consistent with UZS. Due to persistent IOP elevation and the complication of UZS, bilateral deep sclerectomy (DS) was performed, resulting in adequate IOP control. (10-mmHg OD, 17-mmHg OS) and gradual improvement in pupillary function. No further complications were observed. The case was classified under PPV Type II based on the coexistence of vascular and pigmentary anomalies. A review of the literature confirms the rarity of such a constellation of findings and the sparsity of reported bilateral UZS following MP-TSCPC. Conclusion and Importance: This case highlights that PPV Type IIb requires careful examination because of the risk of associated glaucoma. UZS should be considered as a possible complication after MP-TSCPC, especially when both eyes are treated. In complex cases with vascular involvement, DS can provide effective and safe IOP control.

Indexed as

oculodermal melanocytosisphakomatosis pigmentovascularisUrrets-Zavalia syndromeUZS

Identifiers

PMID42088778
PMCPMC13136672

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.